Page last updated: 2024-10-18

dihydroxyphenylalanine and Dysplastic Nevus Syndrome

dihydroxyphenylalanine has been researched along with Dysplastic Nevus Syndrome in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Dysplastic Nevus Syndrome: Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"To determine whether plasma 5-S-cysteinyldopa levels are useful in following up patients at risk for melanoma, we measured plasma 5-S-cysteinyldopa in patients with dysplastic nevus syndrome and/or malignant melanoma and in control subjects."7.67Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. ( Fletcher, WS; Ilias, A; Palmquist, M; Peterson, LL; Tucker, MA; Woodward, WR, 1988)
"To determine whether plasma 5-S-cysteinyldopa levels are useful in following up patients at risk for melanoma, we measured plasma 5-S-cysteinyldopa in patients with dysplastic nevus syndrome and/or malignant melanoma and in control subjects."3.67Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects. ( Fletcher, WS; Ilias, A; Palmquist, M; Peterson, LL; Tucker, MA; Woodward, WR, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peterson, LL1
Woodward, WR1
Fletcher, WS1
Palmquist, M1
Tucker, MA1
Ilias, A1
Stierner, U1
Augustsson, A1
Rosdahl, I1
Kågedal, B1
Suurküla, M1

Other Studies

2 other studies available for dihydroxyphenylalanine and Dysplastic Nevus Syndrome

ArticleYear
Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects.
    Journal of the American Academy of Dermatology, 1988, Volume: 19, Issue:3

    Topics: Adult; Aged; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Cysteinyldopa; Diagnosis, Diff

1988
UVB-induced melanocyte proliferation and 5-S-cysteinyldopa excretion in dysplastic nevus syndrome.
    Photo-dermatology, 1988, Volume: 5, Issue:5

    Topics: Adult; Aged; Cell Count; Cell Division; Chromatography, High Pressure Liquid; Cysteinyldopa; Dihydro

1988